Levocetirizine + Montelukast

Composition

The formulation contains Levocitrazine, Montelukast as the active ingredient.

Indications

Indicated for the treatment of allergic rhinitis and asthma.

Side effects

Side effects may include drowsiness, headache, and gastrointestinal disturbances.

Precautions

caution when driving or operating machinery due to potential drowsiness.

Contraindications

Contraindicated in patients with severe renal impairment, phenylketonuria (for formulations containing aspartame).

Dosage and administration

As directed by the physician

Countries

Worldwide

Available Forms

Tablet

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai